Spectral Medical Inc
EDT
Company Profile
Business description
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Contact
135 The West Mall
Unit 2, Finance
TorontoONM9C 1C2
CANT: +1 416 626-3233
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
29
Stocks News & Analysis
stocks
Is this ASX share a long-term buy?
Current operating conditions are challenging but over the long-term prospects are better.
stocks
Why Guzman and Reece's share reversals have a lot in common
Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,477.30 | 20.70 | -0.24% |
| CAC 40 | 8,143.92 | 92.85 | 1.15% |
| DAX 40 | 22,794.11 | 383.84 | 1.71% |
| Dow JONES (US) | 43,422.20 | 39.01 | -0.09% |
| FTSE 100 | 8,706.59 | 37.92 | 0.44% |
| HKSE | 23,787.93 | 753.91 | 3.27% |
| NASDAQ | 19,013.33 | 13.06 | -0.07% |
| Nikkei 225 | 38,142.37 | 95.42 | -0.25% |
| NZX 50 Index | 12,452.46 | 145.19 | 1.18% |
| S&P 500 | 5,946.62 | 8.63 | -0.14% |
| S&P/ASX 200 | 8,240.70 | 11.20 | -0.14% |
| SSE Composite Index | 3,380.21 | 34.17 | 1.02% |